NEVVI Medicare utilization intelligence

Geography — Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion (Q2043) in Medicare, the United States

Geography · Q2043 · National · CY2024
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Where Q2043 is billed · every state market

Every state market that bills this code, by services, each linked to its own market page.

← Back to the market overview